ALYSON LANG: Open Payments
NPI 1023352366 · PASADENA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$686 in 20 payments from 10 companies in 2025. Trend: 2023 $823 · 2024 $477 · 2025 $686
Food & beverage: $686
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 6 | $329 |
| AstraZeneca Pharmaceuticals LP | 2 | $122 |
| PFIZER INC. | 3 | $50 |
| Corcept Therapeutics | 2 | $43 |
| Lundbeck LLC | 2 | $36 |
| Novo Nordisk Inc | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Lilly USA, LLC | 1 | $24 |
| Amgen Inc. | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
Products named: Dexcom G6 Transmitter, AIRSUPRA, DEXCOM G7 GSS (161), Korlym, VYEPTI, PREVNAR 20, Wegovy, CAPLYTA.
Industry payments across MD — which companies pay providers there.
